Integrated Monitoring: Applying technology and analytics to drive monitoring efficiencies

Webcast

Webcast

Thursday, May 26, 2022 at 11am EDT 1. Learn of a new integrated monitoring approach to speed your trials, improve study quality while mitigating risks 2. Understand how integrated monitoring solutions are using innovative technology and analytics to streamline and automate processes

Register free: http://www.appliedclinicaltrialsonline.com/act_w/monitoring

Event overview:

Clinical monitoring is a critical, essential element of executing a successful clinical trial. CRAs work tirelessly to ensure the quality of data and adherence to protocols throughout the study. Now there is a new, integrated monitoring approach that is improving the efficiencies and quality of your study, at the study, site and subject level.

At the core is an RBQM technology platform providing a data-driven approach to deliver rapid insights through enhanced and predictive analytics, using AI/ML and innovative techniques to automate appropriate project team monitoring actions, resulting in faster issue resolution and increased overall study quality.

In this Applied Clinical Trials webinar, you’ll learn how the all-new SaaS-based Risk-Based Quality Management (RBQM) with a CRA-central monitor solution is improving study quality while mitigating risks in your study.

3 Key take-aways

Register now to learn how technology and analytics are:

  • Enabling faster, better insights that drive the next best action in your study
  • Streamlining and automating processes with integrated monitoring solutions
  • Increasing study quality and speed, while mitigating risks

In case of any questions, please ciontact Julia Longo at jlongo@mjhlifesciences.com

© 2022. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union, and various other countries.

Speakers

Gayle Hamilton
Director, RBQM, Digital Trial Management Suite
IQVIA

Gayle Hamilton has been working in the industry since 1996 and joined IQVIA in 2004. She has been working in Risk-Based Monitoring as a Project Advisor since November 2015. She is experienced as a seasoned Project Lead with a strong background in clinical operations and project management; all aspects of clinical trial phases and therapeutic areas; supporting study trial teams and IT development in RBM implementation; and, development of processes, tools and systems for IQVIA’s Risked Based Monitoring solutions where she has 10+ years of experience. She is now in RBQM product implementation and project advisory role.

Gayle is also experienced in assuring high quality business performance of clinical operations within global projects. Prior to working for IQVIA, Gayle performed clinical research for 10 years in the allergy and asthma field. Outside of work, she enjoys spending time with her family, raising Monarch butterflies and outdoor activities.

Adrian Kizewski
Product Manager, Risk Based Quality Management (RBQM), Digital Trial Management Suite
IQVIA

Adrian brings expertise spanning R&D and clinical life sciences, business analysis, process design & improvement, and product implementation. He is currently a lead for IQVIA’s Digital Trial Management Suite focused on the Risk Based Quality Management SaaS solution. Adrian holds an MBA from the McDonough School of Business at Georgetown University in addition to an MSc in Pharmacology from The Johns Hopkins University School of Medicine and a BSc in Biochemistry from Temple University.

Register free: http://www.appliedclinicaltrialsonline.com/act_w/monitoring

Related Content
© 2024 MJH Life Sciences

All rights reserved.